MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9.49 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹1,212,944 Cr |
| Mar2021 | ₹13 Cr |
How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.49 Cr | -35.54 | |
| Mar2024 | ₹15 Cr | -1.13 | |
| Mar2023 | ₹15 Cr | -100.00 | |
| Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
| Mar2021 | ₹13 Cr | - | |
Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹490.4 Cr | -2.8% | -3.9% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -2.8% |
-3.9% |
-25.7% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses